BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11877882)

  • 1. [The psychopathological symptoms of the preclinical stages of Alzheimer's disease].
    Bidzan L
    Psychiatr Pol; 2001; 35(6):1019-32. PubMed ID: 11877882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The psychopathological pictures of the early stages of dementia syndromes (vasogenic and of Alzheimer's type)].
    Bidzan L
    Psychiatr Pol; 1998; 32(5):583-95. PubMed ID: 9920996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and psychological symptoms in the preclinical stage of Alzheimer's disease.
    Bidzan L; Pachalska M; Grochmal-Bach B; Bidzan M; Cieslukowska A; Pufal A
    Med Sci Monit; 2008 Sep; 14(9):CR473-9. PubMed ID: 18758418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Depressive symptoms in the preclinical period of dementia of the Alzheimer's type].
    Bidzan L
    Psychiatr Pol; 1999; 33(5):747-60. PubMed ID: 10761440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia].
    Krzymińska E; Rossa G; Krzymiński S
    Psychiatr Pol; 1993; 27(2):129-38. PubMed ID: 8378466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral disturbances in Alzheimer's disease: a non-pharmacological therapeutic approach.
    Silvestri A; Rosano G; Zannino G; Ricca F; Marigliano V; Fini M
    Arch Gerontol Geriatr Suppl; 2004; (9):379-86. PubMed ID: 15207436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The loss of close person and the cognitive functions of persons with Alzheimer type dementia].
    Bidzan L; Łapin J; Sołtys K; Turczyński J
    Psychiatr Pol; 2002; 36(5):695-702. PubMed ID: 12491980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of progression from mild cognitive impairment to Alzheimer disease.
    Palmer K; Berger AK; Monastero R; Winblad B; Bäckman L; Fratiglioni L
    Neurology; 2007 May; 68(19):1596-602. PubMed ID: 17485646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical heterogeneity of dementia of the Alzheimer type].
    Gavrilova SI; Korsakova NK; Vavilov SB; Selezneva ND; Kalyn IaB; Dybovskaia NR; Roshchina IF; Medvedev LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):44-50. PubMed ID: 2176041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sleep disorders in the preclinical period of the Alzheimer's disease].
    Bidzan L; Grabowski J; Dutczak B; Bidzan M
    Psychiatr Pol; 2011; 45(6):851-60. PubMed ID: 22335128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
    Hannesdóttir K; Snaedal J
    Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project.
    Bäckman L; Small BJ
    Physiol Behav; 2007 Sep; 92(1-2):80-6. PubMed ID: 17573076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.